LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

European Biotech Week 2022: Bringing Biotech to Local Communities

24/10/2022
NEWS RELEASE

Brussels, 24 October 2022 – Since its first edition in 2013, EuropaBio’s European Biotech Week has established itself as a week of celebrations of life sciences and biotechnology, taking place annually all across the continent at the end of September, and this year was no exception: from September 26 to October 2, 15 European countries hosted almost 100 biotech-focused activities and events (94 in total) that educated, engaged and excited local communities all over Europe.

Biotech and life sciences associations (at national and local level), but also schools, universities, research centres, government institutions, companies and science museums (for a total of 106 organizations) partnered for the 10th edition of the European Biotech Week.

Target audiences  included students (across all age groups), researchers, investors, companies, policy makers and the general public. Initiatives throughout the week were as diverse as the organisers themselves, and included: conferences, debates, workshops, job fairs, exhibitions and site-visits with companies, research institutes and museums (online, on-site and in hybrid formats).

The aim of the #EuropeanBiotechWeek was to encourage the general public to dive into biotechnology, which is a key part of our everyday lives. In this perspective, EuropaBio hosted multiple virtual events in Brussels around the benefits of biotech for people and planet:

  • Biotechnology for society, sustainability and economies – transformative science for a changing world | The kick-off webinar opened the week with a look at biotechnology as the centre of Europe’s transformation to a healthy, sustainable and competitive economy and society. Four EuropaBio Board Members from across Europe’s biotechnology spectrum (Patricia Malarkey – DSM, Stefan Buchholz – Evonik, Tom Bols – PTC Therapeutics, Annemiek Verkamman – HollandBio) discussed biotech in action and its benefits in our everyday lives, as well as how it supports employment, economic development and Europe’s place in the world.
  • Innovative technologies in the EU green transition – spotlight on industrial biotechnology | The second virtual event focused on innovative solutions that can contribute towards the green transition, with an emphasis on industrial biotechnology. The three panelists (Marc Leclerc – Novozymes, Rachel Melnick – Agriculture & Food Systems Institute, Hans Genee – Biosyntia) zoomed in on products of industrial biotechnology and their benefits and challenges, also linking to the EU GMO regulatory framework and recent developments on new genomic techniques.
  • At the cutting edge of biotechnology for cardiovascular diseases: a World Heart Day special edition webinar | The last webinar (held on World Heart Day) highlighted how healthcare biotechnology has the potential to transform how healthcare is delivered to patients, both in terms of innovative treatments, but also via use of innovative prevention, screening, and testing measures. The speakers (Marius Geanta – FH Europe, Florian Kronenberg – Medical University of Innsbruck, Lena Lymperopoulou – Novartis) discussed how biomarker testing for genetically inherited risk factors for cardiovascular diseases is opening up new frontiers in healthcare, and saving lives across the world.

EuropaBio Director-General, Claire Skentelbery, commended: “We recognise how important it is to engage with everybody in Europe on the benefits and potential of biotechnology. It is fantastic to see more and more experts engaging in communication about science and involving non-scientists. It gives us great pride in EuropaBio to see that communities across Europe have learnt more about this complex and exciting sector, and we wholeheartedly thank all the biotech supporters who have contributed to this year’s amazing programme.”

For more details about this edition of the European Biotech Week, we invite you to visit www.biotechweek.org or to download the full report.

European Biotech Week 2022 - PRESS RELEASE


Download

European Biotech Week 2022 - REPORT


Download
2022_10_G_PR_European-Biotech-Week-2022_ReportDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

22/05/2025

Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World


Read more
21/05/2025

Ensuring Biotech Integration in the Single Market


Read more
16/04/2025

EuropaBio position on the EU Life Sciences Strategy


Read more

Important links

  • Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World
  • Ensuring Biotech Integration in the Single Market

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.